Refine
Year of publication
Document Type
- Article (15385) (remove)
Language
- English (15385) (remove)
Has Fulltext
- yes (15385)
Keywords
- taxonomy (413)
- new species (176)
- morphology (98)
- inflammation (91)
- COVID-19 (75)
- distribution (74)
- biodiversity (63)
- SARS-CoV-2 (60)
- phylogeny (53)
- Englisch (50)
Institute
- Medizin (4838)
- Physik (1655)
- Biowissenschaften (1025)
- Biochemie und Chemie (756)
- Frankfurt Institute for Advanced Studies (FIAS) (710)
- Geowissenschaften (538)
- Informatik (391)
- Senckenbergische Naturforschende Gesellschaft (332)
- Institut für Ökologie, Evolution und Diversität (330)
- Gesellschaftswissenschaften (289)
- E-Finance Lab e.V. (277)
- Biodiversität und Klima Forschungszentrum (BiK-F) (266)
- Psychologie (265)
- Biochemie, Chemie und Pharmazie (263)
- Extern (185)
- Exzellenzcluster Makromolekulare Komplexe (173)
- Pharmazie (171)
- Psychologie und Sportwissenschaften (147)
- Wirtschaftswissenschaften (146)
- Georg-Speyer-Haus (117)
- Geowissenschaften / Geographie (113)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (108)
- Neuere Philologien (107)
- Sportwissenschaften (105)
- Sonderforschungsbereiche / Forschungskollegs (103)
- Rechtswissenschaft (97)
- MPI für Biophysik (91)
- Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit (ZAFES) (91)
- MPI für Hirnforschung (83)
- Mathematik (80)
- Institut für Deutsche Sprache (IDS) Mannheim (79)
- Buchmann Institut für Molekulare Lebenswissenschaften (BMLS) (62)
- Philosophie (61)
- Exzellenzcluster Die Herausbildung normativer Ordnungen (57)
- Informatik und Mathematik (55)
- SFB 268 (49)
- Deutsches Institut für Internationale Pädagogische Forschung (DIPF) (48)
- Erziehungswissenschaften (47)
- Geographie (47)
- ELEMENTS (40)
- MPI für empirische Ästhetik (36)
- Institut für Sozialforschung (IFS) (33)
- Geschichtswissenschaften (30)
- Kulturwissenschaften (25)
- Sprach- und Kulturwissenschaften (25)
- Ernst Strüngmann Institut (24)
- Präsidium (24)
- Sustainable Architecture for Finance in Europe (SAFE) (21)
- Center for Membrane Proteomics (CMP) (18)
- Philosophie und Geschichtswissenschaften (18)
- Exzellenzcluster Herz-Lungen-System (16)
- Universitätsbibliothek (16)
- Starker Start ins Studium: Qualitätspakt Lehre (15)
- House of Finance (HoF) (13)
- Institut für sozial-ökologische Forschung (ISOE) (12)
- Sprachwissenschaften (11)
- Zentrum für Interdisziplinäre Afrikaforschung (ZIAF) (11)
- Helmholtz International Center for FAIR (9)
- Interdisziplinäres Zentrum für Neurowissenschaften Frankfurt (IZNF) (9)
- Center for Scientific Computing (CSC) (7)
- DFG-Forschergruppen (7)
- LOEWE-Schwerpunkt für Integrative Pilzforschung (7)
- Cornelia Goethe Centrum für Frauenstudien und die Erforschung der Geschlechterverhältnisse (CGC) (5)
- Goethe-Zentrum für Wissenschaftliches Rechnen (G-CSC) (5)
- Institute for Monetary and Financial Stability (IMFS) (5)
- keine Angabe Institut (5)
- Hochschulrechenzentrum (4)
- Institut für Wirtschaft, Arbeit, und Kultur (IWAK) (4)
- Evangelische Theologie (3)
- Hessische Stiftung für Friedens- und Konfliktforschung (HSFK) (3)
- LOEWE-Schwerpunkt Außergerichtliche und gerichtliche Konfliktlösung (3)
- Universität des 3. Lebensalters e.V. (3)
- Zentrum für Nordamerika-Forschung (ZENAF) (3)
- Center for Financial Studies (CFS) (2)
- Interdisziplinäres Zentrum für Ostasienstudien (IZO) (2)
- Katholische Theologie (2)
- Sigmund-Freud Institut – Forschungsinstitut fur Psychoanalyse und ihre Anwendungen (2)
- Zentrum für Weiterbildung (2)
- (1)
- Akademie für Bildungsforschung und Lehrerbildung (bisher: Zentrum für Lehrerbildung und Schul- und Unterrichtsforschung) (1)
- Diagnostic Center of Acute Leukemia (1)
- Europäische Akademie der Arbeit in der Universität Frankfurt am Main (1)
- Fachübergreifend (1)
- Fachübergreifende Einrichtungen (1)
- Frobenius Institut (1)
- Institut für Bienenkunde (1)
- Wilhelm-Merton-Zentrum (1)
- studiumdigitale (1)
Viruses that carry a positive-sense, single-stranded (+ssRNA) RNA translate their genomes soon after entering the host cell to produce viral proteins, with the exception of retroviruses. A distinguishing feature of retroviruses is reverse transcription, where the +ssRNA genome serves as a template to synthesize a double-stranded DNA copy that subsequently integrates into the host genome. As retroviral RNAs are produced by the host cell transcriptional machinery and are largely indistinguishable from cellular mRNAs, we investigated the potential of incoming retroviral genomes to directly express proteins. Here we show through multiple, complementary methods that retroviral genomes are translated after entry. Our findings challenge the notion that retroviruses require reverse transcription to produce viral proteins. Synthesis of retroviral proteins in the absence of productive infection has significant implications for basic retrovirology, immune responses and gene therapy applications.
We examined the feedback between the major protein degradation pathway, the ubiquitin-proteasome system (UPS), and protein synthesis in rat and mouse neurons. When protein degradation was inhibited, we observed a coordinate dramatic reduction in nascent protein synthesis in neuronal cell bodies and dendrites. The mechanism for translation inhibition involved the phosphorylation of eIF2α, surprisingly mediated by eIF2α kinase 1, or heme-regulated kinase inhibitor (HRI). Under basal conditions, neuronal expression of HRI is barely detectable. Following proteasome inhibition, HRI protein levels increase owing to stabilization of HRI and enhanced translation, likely via the increased availability of tRNAs for its rare codons. Once expressed, HRI is constitutively active in neurons because endogenous heme levels are so low; HRI activity results in eIF2α phosphorylation and the resulting inhibition of translation. These data demonstrate a novel role for neuronal HRI that senses and responds to compromised function of the proteasome to restore proteostasis.
The nine genera of Malagasy spittlebug are revised, with the addition of new characters, facilitating the identification of the species. Nesaulax Jacobi, 1917, is synonymized with Amberana Distant, 1908, leading to a new combination for Amberana vittipennis (Bergroth, 1894). A new endemic genus Soulierana Bucher & Bouteille gen. nov. is proposed for two species originally placed in Literna Stål, 1866, based on morphological characters of the head, tegmina and male genitalia. Also, three new species are described in this genus: Soulierana bigidea Bucher gen. et sp. nov., Soulierana claudinae Bouteille gen. et sp. nov. and Soulierana kelymena Le Cesne gen. et sp. nov. Pictures of species and drawings of the male genitalia for all genera, with the exception of Rhinaulax Amyot & Serville, 1843, Alluaudensia Lallemand, 1920 and Literna, are included. An identification key is available in both a dichotomous format and an interactive format (Xper3).
Systematics of the Sierra Nevada endemic earwig: Eulithinus analis (Forficulidae, Dermaptera)
(2024)
Since the description of Eulithinus analis (Rambur, 1838) the taxonomic position of this Sierra Nevada endemic earwig has been controversial. It has been subdivided in different taxa, assigned to various genera or transferred to different subfamilies. With the aim of clarifying its systematics, we performed a mitochondrial phylogeographic analysis using specimens from different localities of Sierra Nevada representing the diverse phenotypes treated as differentiated taxa until now, and a phylogenetic analysis including representatives of apparently distant, but morphologically close, relatives. The phylogenetic and phylogeographic results obtained using mitochondrial (cytb, cox1) and nuclear (ITS2) markers and the study of morphological characters, indicate that the Sierra Nevada Mountain Range harbors a single species of the genus Eulithinus. Based on these molecular data, the morphological characters used to date in the internal taxonomy of this group of earwigs, especially size and shape of the cerci, lack diagnostic validity and show a large inter- and intra-populational variability. These results imply the synonymy of Eulithinus montanus (Steinmann, 1981) with Eulithinus analis (Rambur, 1838) syn. nov. and the reconsideration of Eulithinus analis outside the subfamily Allodahliinae. We established the synonymy between Eulithinus analis (Rambur, 1838) and Forficula brevis Rambur, 1838 syn. nov., a name that must be removed from the synonymy of Forficula decipiens Gené, 1832.
A comparison of different APTT-reagents, heparin-sensitivity and detection of mild coagulopathies
(1992)
The activated partial thromboplastin time (aPTT) is widely used to detect coagulation abnormalities or to monitor heparin treatment.
Many commercial aPTT-reagents are available which contain different phospholipid reagents and activators. In the present study 3 aPTT-reagents (aPTT-D, Instrumentation Laboratory, Neothromtin, Behring, PTTa, Boehringer) were compared using a computerized centrifugal analyzer. One aPTT-reagent (Pathromtin, Behring) was tested on a semiautomated coagulometer. Instrument precision was evaluated using aPTT-D as reagent.
Comparative tests were performed on plasma samples of 40 healthy donors, 3 patients with mild von Willebrand's disease (vWd), W patients with heaemophilia or subhaemophilia A, 1 patient with subhaemophilia A and vWd, 8 patients treated with subcutaneous injection of unfractionated heparin (UFH) and 14 patients treated with subcutaneous injection of a low molecular weight heparin (LMWH).
aPTT-D was the most sensitive reagent to detect mild vWd while Pathromtin detected none of these defects. In patients with heamophilia A and subhaemophilia A aPTT-D, Neothromtin and PTTa detected the abnormality in nearly all tested samples while Pathromtin was less sensitive.
Patients treated with subcutaneously applied UFH or LMWH often had a prolonged aPTTt especially when aPTT-D and Neothromtin were used as reagents.
Background: Hundreds of West African healthcare workers (HCW) have become ill with Ebola virus disease (EVD) and died during the recent outbreak. The occurrence of occupational infections in laboratories could be due to the lack of use of personal protective equipment, the failure to implement specific regulations about the use of equipment and how to work with hazardous materials. Our study attempted to assess the information as well as training level of HCW of a German high level isolation unit and their concern over an occupationally acquired EVD.
Methods: During the recent Ebola virus outbreak a survey was conducted among HCWs, using an anonymous questionnaire.
Results: Although 70% of our total study population stated that they have all the information needed to care for Ebola patients, only 18.2% of laboratory workers and 29.4% of the HCW of the virology department felt sufficiently trained. The HCW rated the Internet (64.3%) and the daily press (54.3%) as the most important sources of information. Medical literature (45.7%) and official institutions (40.4%) were rated less often.
Conclusions: Formulated pointedly, the HCW turned to popular science to get the information they need to feel safe. Further in house training regarding practical skills and reference to scientific literature would be a better solution to ensure workplace safety.
Herpes simplex virus type 2 (HSV-2) is the main cause of herpes genitalis, a recurrent sexually transmitted disease. By the use of routine Serologie methods (complement fixation test, enzyme immunoassay), virus carriers are difficult to identify because of strong antibody cross reactions with antigens of HSV-1 which is ubiquitously spread throughout the population. We introduce a microtechnique Western blot system loaded with HSV-1 and HSV-2 type-specific and common antigens on separated nitrocellulose strips. By the simultaneous evaluation of Immunologie reactions with both strips, the occurrence of HSV-2 specific antibodies can be sensitively detected in serum specimens containing antibodies to HSV-1. A total of 158 serum specimens were analyzed and the results obtained by Western blot were compared to those of a screening ELISA and virus isolation performed with smears of herpes lesions.
An agreement of 97.9 % was assessed between Western blot and virus isolation to detect an HSV-1 and HSV-2 infection. Less specific serologic results were produced by the screening ELISA on HSV-2 antibodies which correlated in 85.4 % (41/48) with virus isolation and typing. Concerning HSV-2 antibody testing, Western blot and ELISA showed an overall agreement in 89.8 % of the sera investigated.
As shown by our data, the HSV type specific Western blot proved to be a specific, reproducible and standardized technique. It can be utilized for both sero-epidemiological surveys and determination of the HSV immune status.
Activated blood coagulation factor (F) XIII (FXIIIa), a transglutaminase comprised of two A and two B subunits in a tetrameric structure (A2B2) of 320 kd, has a central role in the haemostatic system by cross-linking fibrin monomers in the final step of blood coagulation, thus stabilizing the fibrin clot and increasing its resistance to fibrinolysis. In addition, FXIIIa is implicated in the cross-linking of several other proteins, such as a-2-antiplasmin, fibronectin, and collagen. The impact of genetic variations of FXIII in thrombotic disorders has not been studied until recently, when a common polymorphism was described as a new candidate genetic factor influencing the risk of thrombotic diseases. This polymorphism results from a G to T transition in codon 34 of exon 2 of the catalytic FXIII A-subunit gene, leading to the substitution of leucine for valine (FXHIVal34Leu) close to the thrombin activation site. Genotype at this polymorphism is closely related to FXIII fibrin cross-linking activity, and FXIIILeu is associated with increased thrombin activation of FXIII with associated changes in fibrin structure. Initially, FXIII Val34Leu was shown to be significantly less common in British patients with a history of myocardial infarction than in controls, suggesting for the first time a new role for FXIII in a polygenic thrombotic disease. In addition to its proposed protective effect against thrombotic heart diseases, the Leu34 allele has also been correlated with protection against venous thromboembolism and thrombotic cerebral artery occlusion, whereas it seems to confer an increased risk for intracerebral haemorrhage. Because this genetic variation is associated with a higher activity of the enzyme, the mechanism accounting for the putative anti-thrombotic effect of FXIII Val34Leu is not well understood. However, it has been hypothesized that increased rates of FXIII activation could lead to ineffective cross-linking, or that the kinetics of the cross-linking reactions may be disrupted because of the effects of FXIIIa on other proteins. Previous s'tudies have demonstrated that the FXIII Val34Leu polymorphism is highly prevalent in ^[[200~several Caucasian populations, with reported Leu34 allele frequencies of around 0.25, whereas it is less prevalent in populations of African and Asian origin. The known significant ethnic heterogeneity linked to the FXIII Val34Leu polymorphism is of relevance when analyzing its role in vascular diseases. In summary, published studies indicate that blood coagulation FXIII is involved in the multifactorial pathogenesis of vascular diseases and suggest a contribution of FXIII Val34Leu in determining the risk of myocardial infarction, stroke and venous thromboembolism.
Highly sensitive qualitative and quantitative automatednucleic acid amplification tests (NATs) that are commercially available for the detection of hepatitis B virus (HBV)infection have been developed only in the last few years.The potential indications for HBV NATs are: follow-up ofchronic hepatitis B, therapy and antiviral resistance monitoring, determination of infectivity and transmission risk,detection of occult (HBsAg-negative and HBV DNA-positive) infection and mutant virus which may escape serologic diagnosis, blood donor screening, and resolution ofunusual or discordant serologic constellations. Although NATs are now widely implemented in the routine diagnosis of clinical laboratories, there are several importantissues which need to be further investigated. Standardisation of NATs used for the monitoring of antiviral therapyand follow-up of chronic infection is still lacking, and theclinical significance of HBV DNA levels needs to be clarified. The influence of genetic variability in terms of genotype variation has been poorly investigated so far.Although there are highly sensitive automated NATs forblood donor screening available, their implementation is still subject to discussion and certain countries rejectedHBV DNA testing for blood donation for reasons of poor cost-effectiveness.
Women with thrombophilic defects have been shown to be at increased risk, not only of pregnancy associated thromboembolism but also of other vascular complications of pregnancy, including preeclampsia and fetal loss. First trimester fetal loss is associated with factor V Leiden mutation, activated protein C resistance without factor V Leiden mutation and prothrombin G20210A mutation. Late nonrecurrent fetal loss is associated with factor V Leiden mutation, prothrombin mutation and protein S deficiency. Concerning acquired thrombophilia, recurrent fetal loss is a well-documented finding in patients with antiphospholipid antibodies. Associations between thrombophilia polymorphisms and an increased risk of intrauterine growth restriction have been discussed in small series of cases but could not be confirmed in large scale studies. Frequencies for anticardiolipin antibodies or lupus anticoagulants and antinuclear antibodies were significantly higher in women with infants small for gestational age compared to controls. Concerning preeclampsia, gestational hypertension and thrombophilia, a number of studies have examined these relationships with conflicting results. For factor V Leiden, MTHFR C677T and prothrombin mutation, no association with preeclampsia was observed, when severe cases were excluded. If studies were restricted to those of severe preeclampsia, an association with the factor V Leiden mutation was apparent and, to a lesser extent, with the MTHFR-mutation. For antithrombotic therapy, it was shown that in women with antiphospholipid syndrome and recurrent pregnancy loss, unfractionated heparin plus lowdose aspirin results in significantly better gestational outcome than lowdose aspirin alone. Concerning therapy of women with inherited thrombophilia and pregnancy loss, only small, uncontrolled studies are available, demonstrating improved pregnancy outcome when low molecular weight heparin (LMWH) is used for treatment. In conclusion, heritable thrombophilia and the antiphospholipid-syndrome are major causes of fetal loss after exclusion of other underlying pathologies like chromosomal abnormalities, and screening should be recommended. LMWH with or without aspirin may be used for treatment. There is little value in antenatal screening for prothrombotic polymorphisms to predict the development of small for gestational age infants, preeclampsia or gestational hypertension.